The Enterprise Value as of November 2024 (TTM) for Avenue Therapeutics, Inc. (ATXI) is -1724348.00

According to Avenue Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1724348.00. This represents a change of -100.93% compared to the average of 184.90M of the last 4 quarters.

Avenue Therapeutics, Inc. (ATXI) Historical Enterprise Value (quarterly & annually)

How has ATXI Enterprise Value performed in the past?

The mean historical Enterprise Value of Avenue Therapeutics, Inc. over the last ten years is 4.07B. The current -1724348.00 Enterprise Value has changed -104.24% with respect to the historical average. Over the past ten years (40 quarters), ATXI's Enterprise Value was at its highest in in the September 2020 quarter at 13.41B. The Enterprise Value was at its lowest in in the June 2024 quarter at -1118585.40.

Avenue Therapeutics, Inc. (ATXI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Avenue Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avenue Therapeutics, Inc. (ATXI) Average Enterprise Value

How has ATXI Enterprise Value performed in the past?

The current Enterprise Value of Avenue Therapeutics, Inc. (ATXI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Avenue Therapeutics, Inc. (ATXI) Enterprise Value vs. Peers

How is ATXI’s Enterprise Value compared to its peers?

Avenue Therapeutics, Inc.’s Enterprise Value is greater than Hoth Therapeutics, Inc. (-3465209.00), greater than Revelation Biosciences, Inc. (-8887351.00), greater than NeuroBo Pharmaceuticals, Inc. (-5698320.00), less than Virax Biolabs Group Limited (5.47M), less than Panbela Therapeutics, Inc. (5.99M), greater than Palisade Bio, Inc. (-7187172.00), less than Quoin Pharmaceuticals, Ltd. (3.25M), less than ContraFect Corporation (-1135867.00), greater than Allarity Therapeutics, Inc. (-15923227.00), less than CNS Pharmaceuticals, Inc. (2.39M), less than Windtree Therapeutics, Inc. (8.14M), less than Kiromic BioPharma, Inc. (0), less than Biodexa Pharmaceuticals Plc (10.92M), greater than null (-2507878.89),

Build a custom stock screener for Avenue Therapeutics, Inc. (ATXI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avenue Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avenue Therapeutics, Inc. (ATXI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avenue Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.